BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Good news for a new AstraZeneca drug]]>http://www.bloggingstocks.com/2009/08/31/good-news-for-a-new-astrazeneca-drug/http://www.bloggingstocks.com/2009/08/31/good-news-for-a-new-astrazeneca-drug/http://www.bloggingstocks.com/2009/08/31/good-news-for-a-new-astrazeneca-drug/#commentsFiled under: ,

There is good news surfacing for pharmaceutical firm AstraZeneca (NYSE: AZN) this morning. Turns out a new drug produced by AZN helps reduce heart patients' chances of dying by more than 20% when compared to the standard treatment. The drug is designed to prevent blood clots in heart patients.

The study followed 18,624 patients from 2006 to 2008, with roughly half taking rival medicine Plavix and the other half taking AZN's Brilinta. The results show that patients taking Brilinta had a 4.5% chance of dying, compared to a 5.9% chance for patients on Plavix.

Continue reading Good news for a new AstraZeneca drug

Good news for a new AstraZeneca drug originally appeared on BloggingStocks on Mon, 31 Aug 2009 10:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AstraZenecaAZNbloodBrilintadrug studiesDrugStudiesinthenewspharmaceuticalsPlavixstudiesMon, 31 Aug 2009 10:30:00 EST